Comparison of Disease Progression From Prostate Cancer Diagnosis to Metastatic or Nonmetastatic Castrate‐Resistant Prostate Cancer (CRPC) Patients: CaPA Study

Comparison of Disease Progression From Prostate Cancer Diagnosis to Metastatic or Nonmetastatic Castrate‐Resistant Prostate Cancer (CRPC) Patients: CaPA Study

ABSTRACT Background Prostate cancer (PC) patients resistant to castration have decreased survival. Analysis of patient characteristics and disease management can contribute to new strategies to prevent or delay progression to castrate‐resistant prostate cancer (CRPC). This study aimed to characteriz...

Full description

Saved in:
Bibliographic Details
Main Authors: Pedro Costa, António Patrício, João Vasco Barreira, Luís Abranches Monteiro, Luís Campos Pinheiro, Paulo Azinhais, Inês Sequeira, Carlos Rabaça, Ferdinando Pereira, Ricardo Borges, Francisco Botelho, Frederico Reis, José Carvalho, António Canelas, Hugo Coelho, Fernando Vila, Rui Dinis, Sílvia Dias, Ana Cristina Fialho, José Palma dos Reis
Format: Article
Language:English
Published: Wiley 2025-08-01
Series:Cancer Medicine
Subjects:
castrate‐resistant prostate cancer
disease management
prostate cancer
real‐world evidence
time to disease progression
Online Access:https://doi.org/10.1002/cam4.71149
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/cam4.71149

Similar Items